Lars L Thomsen
Overview
Explore the profile of Lars L Thomsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zoller H, Wolf M, Blumenstein I, Primas C, Lindgren S, Thomsen L, et al.
Gut
. 2022 Nov;
72(4):644-653.
PMID: 36343979
Objective: Intravenous iron-a common treatment for anaemia and iron deficiency due to inflammatory bowel disease (IBD)-can cause hypophosphataemia. This trial compared the incidence of hypophosphataemia after treatment with ferric carboxymaltose...
2.
Auerbach M, Achebe M, Thomsen L, Derman R
Obes Surg
. 2022 Jan;
32(3):810-818.
PMID: 35000068
Purpose: Iron deficiency is common following bariatric surgery, and treatment with intravenous iron is often required. This post hoc analysis of data from two randomized, open-label, multicenter trials evaluated the...
3.
Wolf M, Auerbach M, Kalra P, Glaspy J, Thomsen L, Bhandari S
Am J Hematol
. 2020 Oct;
96(1):E11-E15.
PMID: 33027541
No abstract available.
4.
Achebe M, Glaspy J, Kalra P, Auerbach M, Thomsen L, Bhandari S
Am J Hematol
. 2020 Jul;
95(10):E276-E279.
PMID: 32602177
No abstract available.
5.
Bhandari S, Kalra P, Berkowitz M, Belo D, Thomsen L, Wolf M
Nephrol Dial Transplant
. 2020 Feb;
36(1):111-120.
PMID: 32049331
Background: The optimal intravenous (IV) iron would allow safe correction of iron deficiency at a single infusion over a short time. The FERWON-NEPHRO trial evaluated the safety and efficacy of...
6.
Wolf M, Rubin J, Achebe M, Econs M, Peacock M, Imel E, et al.
JAMA
. 2020 Feb;
323(5):432-443.
PMID: 32016310
Importance: Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23-mediated hypophosphatemia. Objective: To compare risks of hypophosphatemia and effects on biomarkers of mineral...
7.
Auerbach M, Henry D, Derman R, Achebe M, Thomsen L, Glaspy J
Am J Hematol
. 2019 Jun;
94(9):1007-1014.
PMID: 31243803
Iron deficiency anemia (IDA) is prevalent, and intravenous iron, especially if given in a single dose, may result in better adherence compared with oral iron. The present trial (FERWON-IDA) is...
8.
Derman R, Roman E, Smith-Nguyen G, Achebe M, Thomsen L, Auerbach M
Am J Hematol
. 2018 Mar;
93(6):E148-E150.
PMID: 29569727
No abstract available.
9.
Holm C, Thomsen L, Langhoff-Roos J
J Matern Fetal Neonatal Med
. 2018 Mar;
32(17):2797-2804.
PMID: 29558233
To explore if intravenous iron isomaltoside (Monofer) leads to a better relief of fatigue than current treatment practice with oral iron in women suffering from severe fatigue after postpartum hemorrhage....
10.
Gybel-Brask M, Seeberg J, Thomsen L, Johansson P
Transfusion
. 2018 Feb;
58(4):974-981.
PMID: 29424441
Background: This trial evaluated the efficacy and safety of intravenous (IV) iron isomaltoside (Monofer) in comparison with placebo in first-time female blood donors. Study Design And Methods: The trial was...